Top segments and regional performance

Last year, the company generated ‪−3.87 M‬ GBP, the most of which — ‪18.69 M‬ GBP — came from its top-performing segment, Investment in Biotechnology and Other Life Sciences, compared to ‪25.39 M‬ GBP the previous year. The greatest contribution came from United Kingdom, which accounted for ‪18.69 M‬ GBP last year, with ‪25.39 M‬ GBP the year before.